Tagged with r&d

Luxembourg The CEO of LIH, Dr Catherine Larue, reveals how LIH’s mission is to translate research knowledge into clinical applications; how since 2008, Luxembourg has made personalized healthcare a priority area, particularly for cancer patients; and why Luxembourg has all the ingredients to be considered amongst the leading life sciences countries…

Luxembourg Marc Schiltz reveals the ambitions of Luxembourg’s National Research Fund (FNR), how his team are encouraging integration and doing far more than just delivering funds to willing researchers. Over the past 5 years, you have taken it upon yourself to internally reorganize the Luxembourg National Research Fund ( FNR), sharpen…

Singapore Biotech CRO InvitroCue Executive director Dr. Steven Fang explains how their technology has disrupted the current clinical trials landscape and the importance of leveraging innovative technologies in meeting future healthcare needs. Could you please introduce to our international readers the main activities of InvitroCue as well as the milestones since…

Luxembourg The CEO of Mitotech introduces the ground-breaking nature of their products; why Mitotech chose Luxembourg to set up its headquarters, as well as the commercial and internalization strategies they will be implementing moving forward. Could you please start by introducing Mitotech to our audience? “Luxembourg has been efficient in communicating…

Luxembourg The General Manager EMEA of Wafergen Biosystems discusses the revolutionary nature of the company’s technologies, how they are at the new frontier of genomic research, why Wafergen set up its EMEA office in Luxembourg,  growth hotspots in the EMEA region, and the recent merger with Japanese group Takara Bio. To…

Luxembourg Rudi Balling discusses his distinguished career in the life sciences, the LCSB’s mission, and Luxembourg’s burgeoning reputation as a biomedicine, interdisciplinary research, and scientific innovation hub. Earlier this year you were awarded the ‘Ordre de Mérite’ for your longstanding contribution to science by the Luxembourg government following a distinguished career…

Luxembourg Marc Diederich, Director of the LBMCC and principal investigator conducting independent research, leading and training a 25-person group including PhD and MSc students, runs us through the raison d’être of the Laboratory, how it is dedicated to the study of the cell and molecular biology of cancer and is focused…

Luxembourg CEO Marc Vandelaer reveals why the Luxembourg biobank IBBL is more than a traditional biobank and how, despite the short time since its inception in 2010, it has begun to receive recognition as a leader within the biobanking industry and a valued bioservice provider. IBBL (Integrated BioBank of Luxembourg) has…

Singapore Mundipharma’s president of Asia Pacific, Latin America, and the Middle East and Africa, Raman Singh defines the underlying drivers behind the company’s explosive growth, while sharing his insights on what it takes for pharma companies to truly succeed in modern-day emerging markets. He also elaborates on Mundipharma’s recent decision to…

Singapore The French ambassador to Singapore showcases the importance of the Asian country to France as a regional hub, the footprint of the French business community in the Singaporean economy, and Singapore’s aim to tailor its R&D efforts. In terms of foreign relations, how strategically important is Singapore to France? More…

Ireland Niall Barron, director of the NICB, discusses the Institute’s research, which has included significant research into Chinese Hamster Ovary (CHO) cell engineering and the identification of micro-RNA mechanisms that can triple protein yields in some limited cases. Could you please introduce the NICB to our global readers and the Institute’s…

Switzerland Thomas Cueni of Interpharma, the Association of Pharmaceutical Research Companies of Switzerland, on the trend of major international companies developing significant operations in Switzerland; how 70 percent of employees at the top pharma companies are foreigners; and why the pharmaceutical industry is the exception to the rule when it comes…